Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Wins FDA Approval for Smallest Catheters

Photonics.com
Jul 2001
COLORADO SPRINGS, Colo., July 27 -- The Spectranetics Corp. has received the approval of the Food and Drug Administration to market its smallest Point 9 catheters with higher laser parameters (i.e., more laser energy). Bench studies and clinical experience in Canada demonstrated to the FDA that some difficult-to-treat lesions -- some that could not previously be treated in a minimally invasive fashion -- can be safely and effectively treated with higher laser parameters delivered through the company's smallest and most maneuverable catheters.

"We were delighted to receive FDA approval for the modified Point 9 catheters so quickly," said Joseph A. Largey, president and CEO of Spectranetics. "Before they can be used, various upgrades must be performed on different generations of CVX-300 lasers in the field. We initially plan to test market the laser upgrades and higher-performance catheters in a small number of accounts."



Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.